COVID-19 pandemic: cardiovascular complications and future implications
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is now a global pandemic with the highest number …
syndrome coronavirus 2 (SARS-CoV-2), is now a global pandemic with the highest number …
SARS-CoV-2 infection and cardiovascular disease: COVID-19 heart
BP Dhakal, NK Sweitzer, JH Indik, D Acharya… - Heart, lung and …, 2020 - Elsevier
Coronavirus disease (COVID-19) is a serious illness caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from …
syndrome coronavirus 2 (SARS-CoV-2). The symptoms of the disease range from …
Management of cardiovascular disease during coronavirus disease (COVID-19) pandemic
Patients with pre-existing cardiovascular disease and risk factors are more likely to
experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID …
experience adverse outcomes associated with the novel coronavirus disease-2019 (COVID …
Cardiovascular manifestations and treatment considerations in COVID-19
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a
pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular …
pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular …
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
TJ Guzik, SA Mohiddin, A Dimarco, V Patel… - Cardiovascular …, 2020 - academic.oup.com
The novel coronavirus disease (COVID-19) outbreak, caused by SARS-CoV-2, represents
the greatest medical challenge in decades. We provide a comprehensive review of the …
the greatest medical challenge in decades. We provide a comprehensive review of the …
COVID-19 and the heart
A Akhmerov, E Marbán - Circulation research, 2020 - Am Heart Assoc
Infection with the severe acute respiratory syndrome novel coronavirus produces a clinical
syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 …
syndrome known as 2019 novel coronavirus disease (COVID-19). When severe, COVID-19 …
Pathogenesis and management of myocardial injury in coronavirus disease 2019
ZY Wei, YJ Geng, J Huang… - European journal of heart …, 2020 - Wiley Online Library
The outbreak of coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a …
syndrome coronavirus 2 (SARS‐CoV‐2) infection, has become a major health crisis and a …
Cardiovascular manifestation and treatment in COVID-19
YB Su, MJ Kuo, TY Lin, CS Chien… - Journal of the …, 2020 - journals.lww.com
The novel coronavirus disease 2019 (COVID-19), with first presentation of atypical
pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 …
pneumonia, has spread rapidly from Wuhan, China, on December 12, 2019 to over 200 …
[HTML][HTML] COVID-19 cardiovascular epidemiology, cellular pathogenesis, clinical manifestations and management
Y Sattar, W Ullah, H Rauf, S Yadav, M Chowdhury… - IJC Heart & …, 2020 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) is a rapidly progressing global pandemic
that may present with a variety of cardiac manifestations including, but not limited to …
that may present with a variety of cardiac manifestations including, but not limited to …
A systematic review of the cardiovascular manifestations and outcomes in the setting of coronavirus-19 disease
The impact of coronavirus disease, 2019 (COVID-19), has been profound. Though COVID-
19 primarily affects the respiratory system, it has also been associated with a wide range of …
19 primarily affects the respiratory system, it has also been associated with a wide range of …